In this article, we are going to take a look at where Inari Medical, Inc. (NASDAQ:NARI) stands against other firms post strong gains amid Wall Street bloodbath. Wall Street’s main indices closed ...

Canaccord downgraded Inari Medical (NARI) to Hold from Buy with a price target of $80, up from $74, after Stryker (SYK) entered into a definitive agreement to acquire Inari in cash for $80 per share.

Capcom delivered some huge news at the Game Awards last year - announcing a sequel to the legendary action-adventure game Okami was in development. It's being helmed by the original game's ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Capcom has announced that a sequel to Ōkami is in development, with Hideki Kamiya returning as a director for the new project. The sequel will be co-developed by multiple studios that include staff ...